FilingPulse

APVO insider transaction filings

Aptevo Therapeutics Inc. — 35 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-10. Screen APVO transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-104Lamothe Jeffrey G. — President and CEO, DirectorOption exercise (M): 961 · Option exercise (M): 961 (derivative) @ $0EDGAR
2026-08-104Harsanyi Zsolt — DirectorOption exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0EDGAR
2026-08-104Kwon SoYoung — SVP, GC, BD & Corp AffairsOption exercise (M): 638 · Option exercise (M): 638 (derivative) @ $0EDGAR
2026-08-104Taylor Daphne — SVP, CFOOption exercise (M): 638 · Option exercise (M): 638 (derivative) @ $0EDGAR
2026-08-104White Marvin L — Executive Chair, DirectorOption exercise (M): 1 · Option exercise (M): 1,666 · Tax withholding (F): 406 @ $4.07 · Option exercise (M): 1 (derivative) @ $0 · Option exercise (M): 1,666 (derivative) @ $0EDGAR
2026-08-104Grant Grady III — DirectorOption exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0EDGAR
2026-08-104Huebner Dirk — SVP, CMOOption exercise (M): 638 · Tax withholding (F): 156 @ $4.07 · Option exercise (M): 638 (derivative) @ $0EDGAR
2026-08-104Kunz Barbara Lopez — DirectorOption exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0EDGAR
2026-08-104Abdun-Nabi Daniel — DirectorOption exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0EDGAR
2026-08-104Niederhuber John — DirectorOption exercise (M): 400 · Option exercise (M): 400 (derivative) @ $0EDGAR
2025-11-124Grant Grady III — DirectorPurchase (P): 13,513 @ $1.49EDGAR
2025-10-034BANK OF AMERICA CORP /DE/ — 10% owner
BANK OF AMERICA NA — 10% owner
BOFA SECURITIES, INC. — 10% owner		Holdings only — no transactions reportedEDGAR
2025-08-084Grant Grady III — DirectorGrant/award (A): 7,200 (derivative) @ $0EDGAR
2025-08-084Huebner Dirk — SVP, CMOGrant/award (A): 11,500 (derivative) @ $0EDGAR
2025-08-084Lamothe Jeffrey G. — EVP, COOGrant/award (A): 17,300 (derivative) @ $0EDGAR
2025-08-084Kunz Barbara Lopez — DirectorGrant/award (A): 7,200 (derivative) @ $0EDGAR
2025-08-084Kwon SoYoung — SVP, GC, BD & Corp AffairsGrant/award (A): 11,500 (derivative) @ $0EDGAR
2025-08-084Niederhuber John — DirectorGrant/award (A): 7,200 (derivative) @ $0EDGAR
2025-08-084White Marvin L — President and CEO, DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-08-084Taylor Daphne — SVP, CFOGrant/award (A): 11,500 (derivative) @ $0EDGAR
2025-08-084Abdun-Nabi Daniel — DirectorGrant/award (A): 7,200 (derivative) @ $0EDGAR
2025-08-084Harsanyi Zsolt — DirectorGrant/award (A): 7,200 (derivative) @ $0EDGAR
2025-07-214Kunz Barbara Lopez — DirectorOption exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0EDGAR
2025-07-214Grant Grady III — DirectorOption exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0EDGAR
2025-07-214Kwon SoYoung — SVP, GC, BD & Corp AffairsOption exercise (M): 3 · Option exercise (M): 3 (derivative) @ $0EDGAR
2025-07-214Lamothe Jeffrey G. — EVP, COOOption exercise (M): 5 · Option exercise (M): 5 (derivative) @ $0EDGAR
2025-07-214Niederhuber John — DirectorOption exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0EDGAR
2025-07-214White Marvin L — President and CEO, DirectorOption exercise (M): 10 · Option exercise (M): 10 (derivative) @ $0EDGAR
2025-07-214Taylor Daphne — SVP, CFOOption exercise (M): 3 · Option exercise (M): 3 (derivative) @ $0EDGAR
2025-07-214Abdun-Nabi Daniel — DirectorOption exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0EDGAR
2025-07-214Harsanyi Zsolt — DirectorOption exercise (M): 1 · Option exercise (M): 1 (derivative) @ $0EDGAR
2025-03-044Kwon SoYoung — SVP, GC, BD & Corp AffairsOption exercise (M): 2 · Option exercise (M): 2 · Option exercise (M): 2 (derivative) @ $0 · Option exercise (M): 2 (derivative) @ $0EDGAR
2025-03-044Lamothe Jeffrey G. — EVP, COOOption exercise (M): 3 · Option exercise (M): 2 · Option exercise (M): 3 (derivative) @ $0 · Option exercise (M): 2 (derivative) @ $0EDGAR
2025-03-044White Marvin L — President and CEO, DirectorOption exercise (M): 8 · Option exercise (M): 6 · Option exercise (M): 8 (derivative) @ $0 · Option exercise (M): 6 (derivative) @ $0EDGAR
2025-03-044Taylor Daphne — SVP, CFOOption exercise (M): 2 · Option exercise (M): 1 · Option exercise (M): 2 (derivative) @ $0 · Option exercise (M): 1 (derivative) @ $0EDGAR

Recent 8-K events — Aptevo Therapeutics Inc.

FiledFormItems reportedSource
2026-08-218-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-08-138-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-278-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-308-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-278-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-05-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-268-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-118-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=APVO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →